Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The multistep hypothesis of ALS revisited
Adriano Chiò, Letizia Mazzini, Sandra D’Alfonso, et al.
Neurology (2018) Vol. 91, Iss. 7
Open Access | Times Cited: 187

Showing 1-25 of 187 citing articles:

Amyotrophic lateral sclerosis
Eva L. Feldman, Stephen A. Goutman, Susanne Petri, et al.
The Lancet (2022) Vol. 400, Iss. 10360, pp. 1363-1380
Open Access | Times Cited: 562
TDP-43 proteinopathies: a new wave of neurodegenerative diseases
Eva Maria Johanna de Boer, Viyanti K Orie, Timothy L. Williams, et al.
Journal of Neurology Neurosurgery & Psychiatry (2020) Vol. 92, Iss. 1, pp. 86-95
Open Access | Times Cited: 277
Emerging insights into the complex genetics and pathophysiology of amyotrophic lateral sclerosis
Stephen A. Goutman, Orla Hardiman, Ammar Al‐Chalabi, et al.
The Lancet Neurology (2022) Vol. 21, Iss. 5, pp. 465-479
Open Access | Times Cited: 253
SOD1 mutations associated with amyotrophic lateral sclerosis analysis of variant severity
Mariusz Berdyński, Przemysław Miszta, Krzysztof Safranow, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 117
Disease-modifying therapies in amyotrophic lateral sclerosis
Adriano Chiò, Letizia Mazzini, Gabriele Mora
Neuropharmacology (2020) Vol. 167, pp. 107986-107986
Closed Access | Times Cited: 98
Physical exercise is a risk factor for amyotrophic lateral sclerosis: Convergent evidence from Mendelian randomisation, transcriptomics and risk genotypes
Thomas Julian, Nicholas Glascow, Adrian Barry, et al.
EBioMedicine (2021) Vol. 68, pp. 103397-103397
Open Access | Times Cited: 91
The gut microbiome: a key player in the complexity of amyotrophic lateral sclerosis (ALS)
Sarah Boddy, Ilaria Giovannelli, Matilde Sassani, et al.
BMC Medicine (2021) Vol. 19, Iss. 1
Open Access | Times Cited: 90
The Peripheral Immune System and Amyotrophic Lateral Sclerosis
Pamela McCombe, John D. Lee, Trent M. Woodruff, et al.
Frontiers in Neurology (2020) Vol. 11
Open Access | Times Cited: 80
The genetic architecture of ALS
Aleksey Shatunov, Ammar Al‐Chalabi
Neurobiology of Disease (2020) Vol. 147, pp. 105156-105156
Open Access | Times Cited: 78
Evidence for polygenic and oligogenic basis of Australian sporadic amyotrophic lateral sclerosis
Emily P. McCann, Lyndal Henden, Jennifer A. Fifita, et al.
Journal of Medical Genetics (2020) Vol. 58, Iss. 2, pp. 87-95
Open Access | Times Cited: 71
Brain modulation by the gut microbiota: From disease to therapy
Sarmistha Mitra, Raju Dash, Amena Al Nishan, et al.
Journal of Advanced Research (2022) Vol. 53, pp. 153-173
Open Access | Times Cited: 54
The amyotrophic lateral sclerosis exposome: recent advances and future directions
Stephen A. Goutman, Masha G. Savelieff, Dae-Gyu Jang, et al.
Nature Reviews Neurology (2023) Vol. 19, Iss. 10, pp. 617-634
Open Access | Times Cited: 42
Biomarkers in Neurodegenerative Diseases: Proteomics Spotlight on ALS and Parkinson’s Disease
Rekha Raghunathan, Kathleen Turajane, Li Chin Wong
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 16, pp. 9299-9299
Open Access | Times Cited: 40
Nutritional and metabolic factors in amyotrophic lateral sclerosis
Albert C. Ludolph, Luc Dupuis, Edward J. Kasarskis, et al.
Nature Reviews Neurology (2023) Vol. 19, Iss. 9, pp. 511-524
Closed Access | Times Cited: 29
Utility of threshold tracking transcranial magnetic stimulation in ALS
Steve Vucic, Mehdi van den Bos, Parvathi Menon, et al.
Clinical Neurophysiology Practice (2018) Vol. 3, pp. 164-172
Open Access | Times Cited: 61
Genetics and Sex in the Pathogenesis of Amyotrophic Lateral Sclerosis (ALS): Is There a Link?
Francesca Trojsi, Giulia D’Alvano, Simona Bonavita, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 10, pp. 3647-3647
Open Access | Times Cited: 60
Proteome Homeostasis Dysfunction: A Unifying Principle in ALS Pathogenesis
Justin J. Yerbury, Natalie E. Farrawell, Luke McAlary
Trends in Neurosciences (2020) Vol. 43, Iss. 5, pp. 274-284
Closed Access | Times Cited: 59
ALS is a multistep process in South Korean, Japanese, and Australian patients
Steve Vucic, Mana Higashihara, Gen Sobue, et al.
Neurology (2020) Vol. 94, Iss. 15
Open Access | Times Cited: 55
Unraveling the complex interplay between genes, environment, and climate in ALS
Rosario Vasta, Ruth Chia, Bryan J. Traynor, et al.
EBioMedicine (2021) Vol. 75, pp. 103795-103795
Open Access | Times Cited: 55
Is Exposure to BMAA a Risk Factor for Neurodegenerative Diseases? A Response to a Critical Review of the BMAA Hypothesis
Rachael A. Dunlop, Banack SA, Bishop SL, et al.
Neurotoxicity Research (2021) Vol. 39, Iss. 1, pp. 81-106
Open Access | Times Cited: 52
Destination Amyotrophic Lateral Sclerosis
Matt Keon, Benjamin Musrie, Marcel E. Dinger, et al.
Frontiers in Neurology (2021) Vol. 12
Open Access | Times Cited: 42
Structural variation analysis of 6,500 whole genome sequences in amyotrophic lateral sclerosis
Ahmad Al Khleifat, Alfredo Iacoangeli, Joke J.F.A. van Vugt, et al.
npj Genomic Medicine (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 38
cGAS and DDX41-STING mediated intrinsic immunity spreads intercellularly to promote neuroinflammation in SOD1 ALS model
Hong Yien Tan, Yean K. Yong, Yuan Chao Xue, et al.
iScience (2022) Vol. 25, Iss. 6, pp. 104404-104404
Open Access | Times Cited: 35
The SOD1-mediated ALS phenotype shows a decoupling between age of symptom onset and disease duration
Sarah Opie-Martin, Alfredo Iacoangeli, Simon Topp, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 35
Targeting phosphoglycerate kinase 1 with terazosin improves motor neuron phenotypes in multiple models of amyotrophic lateral sclerosis
Helena Chaytow, Emily Carroll, David F. Gordon, et al.
EBioMedicine (2022) Vol. 83, pp. 104202-104202
Open Access | Times Cited: 32
Page 1 - Next Page

Scroll to top